Gwo Xi Stem Cell Applied Technology Balance Sheet Health
Financial Health criteria checks 4/6
Gwo Xi Stem Cell Applied Technology has a total shareholder equity of NT$696.1M and total debt of NT$337.3M, which brings its debt-to-equity ratio to 48.5%. Its total assets and total liabilities are NT$1.1B and NT$448.5M respectively.
Key information
48.5%
Debt to equity ratio
NT$337.30m
Debt
| Interest coverage ratio | n/a |
| Cash | NT$329.72m |
| Equity | NT$696.10m |
| Total liabilities | NT$448.52m |
| Total assets | NT$1.14b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 6704's short term assets (NT$363.7M) exceed its short term liabilities (NT$103.4M).
Long Term Liabilities: 6704's short term assets (NT$363.7M) exceed its long term liabilities (NT$345.1M).
Debt to Equity History and Analysis
Debt Level: 6704's net debt to equity ratio (1.1%) is considered satisfactory.
Reducing Debt: 6704's debt to equity ratio has reduced from 55.3% to 48.5% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if 6704 has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if 6704 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.